US 11970534
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
granted A61KA61K39/395A61P
Quick answer
US patent 11970534 (Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof) held by The Board of Regents of the University of Texas System expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K39/395, A61P, A61P1/00, A61P1/16